Here we review evidence that the reactive oxygen species, hydrogen peroxide (H 2 O 2 ), meets the criteria for classification as a neuromodulator through its effects on striatal dopamine (DA) release. This evidence was obtained using fast-scan cyclic voltammetry to detect evoked DA release in striatal slices, along with whole-cell and fluorescence imaging to monitor cellular activity and H 2 O 2 generation in striatal medium spiny neurons (MSNs). The data show that (1) T he striatum is the largest component of the basal ganglia and receives dense dopamine (DA) innervation from midbrain DA neurons in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA).1 The primary targets of these DA afferents are medium spiny neurons (MSNs) that constitute over 90% of the striatal neuronal population and are the main output neurons of this region. Axons arising from midbrain DA neurons form symmetric synapses on MSNs, primarily on spine necks, adjacent to glutamatergic input to spine heads. 2,3 This architectural arrangement enables DA to modulate glutamate-induced MSN excitability with differential outcomes according to whether the target MSN also expresses DA D1 receptors (D1Rs) or DA D2 receptors (D2Rs); DA enhances MSN excitability and up-state MSN spiking via D1Rs and decreases these via D2Rs. 4 Thus, converging glutamatergic and dopaminergic afferents control striatal output at the level of individual spines to regulate motor and cognitive function.4−6 It is relevant to note that D1Rs and D2Rs are predominantly extrasynaptic, 7 so that rapid electrochemical measurements of extracellular DA concentration ([DA] o ) can provide a direct index of DA transmission (e.g., 8−10).The crucial role that DA plays in normal motor behavior has been illuminated by the findings that disturbances in DA function contribute to basal-ganglia circuit dysfunction and that DA depletion leads to the motor deficits of Parkinson's disease.11−13 Thus, elucidating factors that regulate DA release in the striatum is of relevance for understanding the role of DA in normal brain function, as well as for providing therapeutic insight for neuropathological conditions like Parkinson's disease.Our laboratory examines the regulation of striatal DA release using fast-scan cyclic voltammetry (FCV) with carbon-fiber microelectrodes. Because FCV detects dynamic changes in [DA] o with high temporal and spatial resolution, this technique is ideally suited to determine factors that influence the amplitude, duration, and sphere of influence of DA signaling.14−17 Basic factors that we have examined include the pattern of stimulation, Ca 2+ -dependence of DA release, inhibition of DA release by presynaptic DA autoreceptors, and DA clearance by the DA transporter (DAT); we have also examined the effect of a number of local neurotransmitters and neuromodulators that can act on DA axons either directly or indirectly to alter evoked [DA] o (for review, see ref 10).One unconventional and under-appreciated modulator of striatal DA rele...